Fig. 1From: Efficacy of NEMO-binding domain peptide used to treat experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus: an in-vivo studyLeucocyte count (a), and ESR (b) and CRP (c) levels in the Control, Van, NBD + Van, and NBD groups during the 6 weeks follow-up period after debridementBack to article page